Skip to content

Strength gel with Kaempferia Parviflora Extract for improving the appearance of cellulite.

A multi-site, blinded study assessing the efficacy of a lipolytic and adipogenic agent (Kaempferia Parviflora Extract) as a treatment for cellulite

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14923731
Enrollment
40
Registered
2025-04-12
Start date
2025-05-21
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cellulite Skin and Connective Tissue Diseases

Interventions

This pre-post study compares the effect of the test product vs. no product on the appearance of cellulite severity at specific target areas. The treatment comprises the cosmetic product "Strength Gel"

Sponsors

Adipeau Inc
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 09/02/2026: 1. Subjects with mild to severe cellulite as measured by the Merz cellulite dimple scale 2. Female subjects aged 25-75 years 3. Subjects with Fitzpatrick skin types I-VI 4. Subjects who are dependable and able to follow directions, and willing to comply with the schedule of visits 5. Subjects in generally good physical and mental health Previous inclusion criteria: 1. Subjects with mild to severe cellulite as measured by the Merz cellulite dimple scale 2. Female subjects aged 25-65 years 3. Subjects with Fitzpatrick skin types I-VI 4. Subjects who are dependable and able to follow directions, and willing to comply with the schedule of visits 5. Subjects in generally good physical and mental health

Exclusion criteria

Exclusion criteria: 1. Subjects diagnosed or treated for lipedema or lymphedema 2. Subjects with known allergies to the ingredients in the Test Product 3. Subjects who are pregnant or nursing 4. Subjects who anticipate engaging in activities that would result in significant weight loss or gain in the three months following screening

Design outcomes

Primary

MeasureTime frame
Current primary outcome measure as of 14/10/2025: The difference in the grade of cellulite severity on treated areas vs. untreated areas at 12 weeks as measured by the Merz cellulite dimple scale. _____ Previous primary outcome measure: The grade of cellulite severity measured using the Merz Aesthetics cellulite dimple grading scales by blinded evaluators at 12 weeks

Secondary

MeasureTime frame
Current secondary outcome measures as of 14/10/2025: 1. The difference in the grade of cellulite severity in the treated areas after 12 weeks vs. at baseline as measured by the Merz cellulite dimple scale. 2. The difference in cellulite severity in the treated areas after 12 weeks vs. at baseline as measured by Antera 3D imaging. 3. The difference in the ability of evaluators to identify “before” images based on a higher cellulite severity grade being assigned to those images according to the Merz cellulite dimple scale. _____ Previous secondary outcome measures: 1. The grade of cellulite severity measured using the Merz Aesthetics cellulite dimple grading scales by blinded evaluators at baseline and after 12 weeks 2. Cellulite severity measured using Antera 3D imaging at baseline and after 12 weeks 3. The ability of evaluators to identify “before” images based on a higher cellulite severity grade being assigned to those images according to the Merz cellulite dimple scale at one time point

Countries

Australia, England, United Kingdom, United States of America

Contacts

Public ContactIvan Galanin
ivan@adipeau.com+1 9176287920

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026